Legend Biotech Total Assets Growth & History (LEGN)
Legend Biotech's total assets was $1.73B for fiscal 2025.
View full Legend Biotech company overviewLegend Biotech annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.73B | $63.5M | +3.80% |
| 2024 | 2024-12-31 | $1.67B | −$178.4M | −9.65% |
| 2023 | 2023-12-31 | $1.85B | $517.6M | +38.89% |
| 2022 | 2022-12-31 | $1.33B | $211.5M | +18.89% |
| 2021 | 2021-12-31 | $1.12B | $397.4M | +55.03% |
| 2020 | 2020-12-31 | $722.1M | $434.4M | +150.98% |
| 2019 | 2019-12-31 | $287.7M | — | — |
Legend Biotech quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.75B | $61.0M | +3.61% |
| Q1 2026 | 2026-03-31 | $1.60B | −$18.9M | −1.17% |
| Q4 2025 | 2025-12-31 | $1.73B | $63.5M | +3.80% |
| Q3 2025 | 2025-09-30 | $1.71B | −$22.9M | −1.32% |
| Q2 2025 | 2025-06-30 | $1.69B | −$108.3M | −6.02% |
| Q1 2025 | 2025-03-31 | $1.62B | −$159.5M | −8.98% |
| Q4 2024 | 2024-12-31 | $1.67B | −$178.4M | −9.65% |
| Q3 2024 | 2024-09-30 | $1.74B | −$103.5M | −5.63% |
| Q2 2024 | 2024-06-30 | $1.80B | −$132.5M | −6.86% |
| Q1 2024 | 2024-03-31 | $1.78B | — | — |
| Q4 2023 | 2023-12-31 | $1.85B | $517.6M | +38.89% |
| Q3 2023 | 2023-09-30 | $1.84B | — | — |
| Q2 2023 | 2023-06-30 | $1.93B | — | — |
| Q4 2022 | 2022-12-31 | $1.33B | $211.5M | +18.89% |
| Q4 2021 | 2021-12-31 | $1.12B | $397.4M | +55.03% |
| Q2 2021 | 2021-06-30 | $875.1M | — | — |
| Q4 2020 | 2020-12-31 | $722.1M | $434.4M | +150.98% |
| Q4 2019 | 2019-12-31 | $287.7M | — | — |
Legend Biotech total assets trends
Over the last five fiscal years, Legend Biotech's total assets increased from $722.1M to $1.73B, a change of $1.01B. The latest reported quarter, Q2 2026, shows $1.75B.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Legend Biotech source filings ↗